The role of MDR-related proteins in the prognosis of adult acute myeloid leukaemia (AML) with normal karyotype. (Q33268051)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17200981%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

title

The role of MDR-related proteins in the prognosis of adult acute myeloid leukaemia (AML) with normal karyotype (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17200981%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17200981%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Mario Tiribelli

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17200981%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Alessandro Gozzetti

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17200981%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

author name string

Donatella Raspadori

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17200981%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Angela Michelutti

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17200981%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Elisabetta Calistri

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17200981%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Anna Candoni

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17200981%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Alexsia Chiarvesio

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17200981%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Mariapia Lenoci

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17200981%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Domenico Russo

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17200981%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Renato Fanin

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17200981%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

publication date

1 March 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17200981%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

number of pages

6

1 reference

inferred from page(s)

published in

Hematological Oncology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17200981%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17200981%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17200981%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

page(s)

38-43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17200981%20AND%20SRC:MED&resulttype=core&format=json

Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/GIMEMAAML-10 trial

23 December 2019

cites work

1 reference

7 January 2021

Cytogenetics in acute leukemia

1 reference

7 January 2021

Outcome of induction and postremission therapy in younger adults with acute myeloid leukemia with normal karyotype: a cancer and leukemia group B study

1 reference

7 January 2021

P-glycoprotein, lung resistance-related protein and multidrug resistance associated protein in de novo acute non-lymphocytic leukaemias: biological and clinical implications.

1 reference

7 January 2021

Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

1 reference

7 January 2021

Multicentre phase III trial on fludarabine, cytarabine (Ara-C), and idarubicin versus idarubicin, Ara-C and etoposide for induction treatment of younger, newly diagnosed acute myeloid leukaemia patients

1 reference

7 January 2021

Impact of the expression of P glycoprotein, the multidrug resistance-related protein, bcl-2, mutant p53, and heat shock protein 27 on response to induction therapy and long-term survival in patients with de novo acute myeloid leukemia

1 reference

7 January 2021

Multidrug resistance as a potential prognostic indicator in acute myeloid leukemia with normal karyotypes

1 reference

7 January 2021

Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm.

1 reference

7 January 2021

FLT3 mutation and response to intensive chemotherapy in young adult and elderly patients with normal karyotype

1 reference

7 January 2021

Risk assessment in patients with acute myeloid leukemia and a normal karyotype

1 reference

7 January 2021

BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: a Cancer and Leukemia Group B Study

1 reference

7 January 2021

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype

1 reference

7 January 2021